Veracyte | VCYT - Ordinary Share Capital


Veracyte reported $79.79M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Agenus USD 35.32M 2.51M Dec/2025
Agilent USD 282.22M 478K Mar/2026
Anika Therapeutics USD 13.89M 532K Dec/2025
Arrowhead Research USD 137.39M 1.69M Dec/2025
Bruker USD 152.22M 282K Mar/2026
Heron Therapeutics USD 188.31M 4.99M Dec/2025
Illumina USD 151.91M 893K Mar/2026
Intrexon USD 0 0 Jun/2024
Karyopharm Therapeutics USD 18.31M 18.3M Dec/2025
Laboratory Of America USD 82.3M 100K Mar/2026
Ligand Pharmaceuticals USD 19.66M 19.64M Sep/2025
Myriad Genetics USD 93.5M 400K Dec/2025
Rigel Pharmaceuticals USD 17K 158K Jun/2024
Roche Holding CHF 795.62M 699.54K Dec/2025
Siemens EUR 780.74M 6.33M Dec/2025
Sonic Healthcare AUD 4.15B 467K Dec/2024
Thermo Fisher Scientific USD 371.62M 4.09M Mar/2026
Veracyte USD 79.79M 743K Mar/2026
Waters USD 98.17M 89K Mar/2026